About
PROSTPERIA aims at researching and developing new "in silico" screening tests for several cancers. At PROSTPERIA we want to make personalized medicine a reality by steering clear of the "one size fits all" model. Our first test, PROSTia, targets the early detection of prostate cancer.
Technologies
Mobile Friendly
Google Tag Manager
Typekit
AI
IoT
Android
Node.js
Keywords
medical equipment manufacturing
healthtech
medical ai validation
cancer detection
complex phenomena modeling
medical device
cost-effective screening
personalized medicine
personalized screening
risk assessment
healthcare
medical devices
retrospective study
psa test
diagnostic tools
cancer prediction models
biotech
medical research
machine learning
medical ai
personalized diagnostics
biomarker analysis
telemedicine
b2c
biological services
non-invasive test
patient care
clinical validation
early detection
patient data analysis
Company Information
-
Employees 4
-
Founded 2021
Location
10 Rue Victor Poirel, Nancy, Grand Est, France, 54000
